Aa3 on parity debt affirmed; $280M debt affected
New York, October 17, 2014 --
Moody's Rating
Issue: Healthcare Revenue and Refunding Bonds, Series 2014A;
Rating: Aa3; Sale Amount: $204,460,000;
Expected Sale Amount: 10-27-2014; Rating Description:
Revenue: Other
Opinion
Moody's Investors Service has assigned a Aa3 rating to $204.46
million of WellSpan Health's Revenue and Refunding Bonds,
Series 2014A to be issued by the General Authority of Southcentral Pennsylvania.
The rating outlook is stable. At the same time we are affirming
the Aa3 rating on outstanding debt.
RATING RATIONALE:
The affirmation and assignment of the Aa3 bond rating reflect WellSpan's
leading and growing market, multi-year trend of solid operating
performance, growth of absolute balance sheet wealth, and
maintenance of favorable pro forma debt service coverage. The rating
is tempered by WellSpan's defined benefit pension liability,
sizable losses incurred by employed physicians and a heightened competitive
landscape. In addition we note the potential for suppressed consolidated
margins and some integration and operational risk as the system pursues
growth and absorbs new affiliates; particularly as growth may include
operations outside its core service area; we will assess the impact
of these strategies when regulatory approval seems imminent. The
stable rating outlook is based on our expectation that core WellSpan operations
will maintain strong operating performance with cash flow comfortably
covering increased debt service responsibilities.
STRENGTHS
*Leading market position (60%) of the legacy two-county
primary service area encompassing nearly 540,000 people; geographic
reach and diversification expanding with addition of acute care services
in Northern Lancaster County to system's market area. WellSpan
is a founding member of AllSpire Health Partners, created in September
2013. AllSpire Health Partners is an alliance of seven health systems
in New Jersey and Pennsylvania formed to share clinical best practices
under the tenants of the Affordable Care Act.
*Consistent and healthy margins over the last several years with operating
margins ranging between 3.4% and 4.3% and
operating cash-flow margins ranging between 9.0%
and 10.7%
*Nearly all measures of leverage are solid and now compare well with
comparably rated peers, even after giving effect to the current
issuance. Based on fiscal year 2014 Moody's adjusted pro-forma
peak debt service coverage of 5.5 times, and Moody's adjusted
pro-forma debt-to-cashflow of 2.9 times measure
well to Aa3 medians of 6.0 times and 2.6 times, respectively.
*Strong and growing balance sheet position with unrestricted liquidity
of over $1.0 billion, when including immediate reimbursement
from bond proceeds, equating to 286 days of cash on hand at fiscal
yearend 2014, and providing a strong 193% coverage of pro-forma
debt
*Debt structure risks are manageable relative to cash and investments
with 365% monthly liquidity-to-demand debt based
on fiscal year end 2014; 88% of the unrestricted liquidity
is available on a monthly basis
*Strong management capabilities evidenced by the organization's ability
to absorb operating challenges and continue to generate consistently solid
absolute operating cashflow levels, meet or exceed operating budgets,
execute strategies effectively including integrating newly acquired hospitals
*Recent addition of Ephrata Community Hospital expands WellSpan's
presence in broader market, providing platform to grow volumes and
gain market share from competitors. Bringing moderate debt and
manageable operating losses, the System's measures were only
modestly diluted by the addition in FY 2014; management has identified
key revenue and expense initiatives to strengthen Ephrata's financial
profile.
CHALLENGES
*Multiple growth strategies which are being executed simultaneously
can prove to be distracting or operationally dilutive; we will assess
the impact of each if definitive agreements are reached and any required
regulatory approvals seem likely.
*The broader marketplace is increasingly competitive with like sized
and larger competitors driving consolidation across multiple counties.
*Ongoing losses incurred by employed physicians ($29 million
in FY 2014), though value of this strategy remains rooted in System
wide financial and competitive strength.
*Although significantly improved, WellSpan's defined benefit
pension plan carries a $169 million unfunded liability relative
to a pension benefit obligation of $884 million at June 30,
2014; management implemented a soft freeze in 2007.
Outlook
The stable rating outlook is based on our expectation that core WellSpan
operations will maintain strong operating performance with cash flow comfortably
covering increased debt service responsibilities.
What could change the rating--UP
Upward rating movement could follow sustained and significant strengthening
in operating margins, growth in the system's size to provide markedly
greater geographic diversity
What could change the rating--DOWN
A rating downgrade could follow a sustained decline in operating performance;
material weakening of balance sheet strength. Outlook pressure
could result from operational risk as the system expands at an accelerated
pace. In addition, we will assess the impact of any future
affiliations on WellSpan's key credit metrics should definitive agreement(s)
be reached and required regulatory approvals seem imminent.
RATING METHODOLOGY
The principal methodology used in this rating was Not-for-Profit
Healthcare Rating Methodology published in March 2012. Please see
the Credit Policy page on www.moodys.com for a copy of this
methodology.
REGULATORY DISCLOSURES
For ratings issued on a program, series or category/class of debt,
this announcement provides certain regulatory disclosures in relation
to each rating of a subsequently issued bond or note of the same series
or category/class of debt or pursuant to a program for which the ratings
are derived exclusively from existing ratings in accordance with Moody's
rating practices. For ratings issued on a support provider,
this announcement provides certain regulatory disclosures in relation
to the rating action on the support provider and in relation to each particular
rating action for securities that derive their credit ratings from the
support provider's credit rating. For provisional ratings,
this announcement provides certain regulatory disclosures in relation
to the provisional rating assigned, and in relation to a definitive
rating that may be assigned subsequent to the final issuance of the debt,
in each case where the transaction structure and terms have not changed
prior to the assignment of the definitive rating in a manner that would
have affected the rating. For further information please see the
ratings tab on the issuer/entity page for the respective issuer on www.moodys.com.
Regulatory disclosures contained in this press release apply to the credit
rating and, if applicable, the related rating outlook or rating
review.
Please see www.moodys.com for any updates on changes to
the lead rating analyst and to the Moody's legal entity that has issued
the rating.
Please see the ratings tab on the issuer/entity page on www.moodys.com
for additional regulatory disclosures for each credit rating.
Beth I. Wexler
VP - Senior Credit Officer
Public Finance Group
Moody's Investors Service, Inc.
250 Greenwich Street
New York, NY 10007
U.S.A.
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653
Eugene Bradley Spielman
VP - Senior Credit Officer
Public Finance Group
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653
Releasing Office:
Moody's Investors Service, Inc.
250 Greenwich Street
New York, NY 10007
U.S.A.
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653
Moody's assigns Aa3 to WellSpan Health's (PA) $204.5M Ser. 2014A; Outlook is stable